NCT02773758View on ClinicalTrials.gov

Study to Investigate the Efficacy of an Occluding Dentifrice in Providing Relief From Dentine Hypersensitivity

PHASE4CompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

March 11, 2016

Study Completion Date

March 11, 2016

Conditions
Dentin Sensitivity
Interventions
OTHER

Stannous Fluoride Dentifrice

Experimental dentifrice containing 0.454%w/w stannous fluoride (1100ppm fluoride)

OTHER

Sodium monofluorophosphate Dentifrice

Dentifrice containing 0.76% w/w sodium monofluorophosphate (1000ppm fluoride)

Trial Locations (1)

L4W 0C2

GSK Investigational Site, Mississauga

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY